Pharmaceuticals

Industry Trends Show Immunoglobulins Market Set to Expand at 11% CAGR Until 2029

August 21, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Are the Latest Market Insights for the Immunoglobulins Industry?#_x000D_

The immunoglobulins market has experienced significant growth in the past few years. It is projected to expand from $18.85 billion in 2024 to $20.32 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this historical period of growth include an increase in immunodeficiency disorders, an aging population, a rise in the use of immunoglobulins in hospitals, beneficial government reimbursement programs, and a higher prevalence of chronic and autoimmune diseases._x000D_

_x000D_

Expectations are that the immunoglobulins market will experience a rapid expansion in the coming years, with a projected worth of $30.89 billion by 2029, reflecting a compound annual growth rate (CAGR) of 11.0%. The anticipated growth during the forecast period is largely due to increased investments in cutting-edge technology development, escalating awareness around immunodeficiency treatments, a growing preference for immunodeficiency therapies among doctors, emerging markets, and broader applications in sports and fitness. Noteworthy trends for the forecast period consist of the creation of wearable and intelligent compression devices, personalized compression therapy approaches, the incorporation of compression therapy in the management of wound care, a focus on patient comfort and compliance in compression therapy, and strategic partnerships between manufacturers and healthcare providers to strengthen patient outcomes._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp_x000D_

_x000D_

#What Forces Are Driving The Growth Of The Immunoglobulins Industry?#_x000D_

The immunoglobulins market’s expansion is propelled by the escalating geriatric population. Elderly individuals are more susceptible to infectious and auto-immune illnesses. With the use of the immunoglobulin test, the capability of the body to produce antibodies that shield it from bacteria, viruses, and allergies can be assessed. As per a report published by the World Health Organization (WHO), a Switzerland-based institution concerned with global public health, in October 2022, by 2030, one out of every six individuals worldwide is predicted to be at least 60 years old. Moreover, the global population of those aged 60 or more is projected to reach 2.1 billion by 2050. As a result, the rising elderly population is anticipated to augment the demand for the immunoglobulins market during the forecasted timeframe._x000D_

_x000D_

#What Is The Overview Of Market Segmentation In The Immunoglobulins Industry?#_x000D_

The immunoglobulins market covered in this report is segmented – _x000D_

_x000D_

1) By Product: IGG, IGA, IGM, IGE, IGD. _x000D_

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery _x000D_

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)_x000D_

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA_x000D_

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM_x000D_

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE_x000D_

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD_x000D_

_x000D_

#What Future Market Trends Are Projected For The Immunoglobulins Industry?#_x000D_

Key players in the immunoglobulins market are pioneering new products such as intravenous immunoglobulins to broaden their consumer reach, boost sales, and augment revenue. For example, GC Biopharma, a biotech company based in South Korea, announced the launch of ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market in September 2024. This product is intended for treating primary humoral immunodeficiency (PI) in adults 17 years and older, and it is accessible through specialty pharmacies. The launch holds significance as the U.S. is the most sizeable global market for immunoglobulin, estimated at around $11.6 billion. GC Biopharma is aspiring to generate $50 million in sales for ALYGLO in its inaugural year, intending to escalate this to $300 million by 2028. This ambitious growth agenda involves alliances with leading U.S. pharmacy benefit managers and specialty pharmacies, which are essential for efficient distribution of immunoglobulin products._x000D_

_x000D_

#Who Are The Primary Players Operating Across The Global Immunoglobulins Market?#_x000D_

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report_x000D_

_x000D_

#Which Region Offers The Most Growth Potential For The Immunoglobulins Market Through 2029?#_x000D_

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_